Jilin Aodong Pharmaceutical Group Co Ltd (000623) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China.
Total Assets Chart for Jilin Aodong Pharmaceutical Group Co Ltd
Jilin Aodong Pharmaceutical Group Co Ltd (000623) total assets for FY2025 were CNY 34.4B, a 4.3% change from FY2024. Jilin Aodong Pharmaceutical Group Co Ltd's total assets grew from CNY 206.4M in 1993 to CNY 34.4B in 2025 (16574.0% over 32 years). Total assets compound annual growth rate: 5-year CAGR of 4.7%, 10-year CAGR of 5.7%, 20-year CAGR of 14.0%.
Total Assets (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥22.27B
- Implied Share Price
- ¥18.62
- Enterprise Value
- ¥21.69B
- Revenue (TTM)
- ¥2.23B
- EBITDA
- ¥38.93M
- Profit Margin
- 123.25%
- Trailing P/E
- 7.96
- Forward P/E
- 14.62
- Price/Book (MRQ)
- 0.71
- Price/Sales (TTM)
- 10.00
- EV/EBITDA
- 7.70
- EV/Revenue
- 9.74
- Dividend Yield
- 2.68%
- Book Value
- ¥26.86
- Free Cash Flow (FY2025)
- ¥143.81M
- Free Cash Flow Yield
- 0.65%
Snapshot as of 28th August 2026 — not point-in-time controlled, may lag the live market by a few days.